Literature DB >> 361223

Phase I clinical studies with gallium nitrate.

A Y Bedikian, M Valdivieso, G P Bodey, M A Burgess, R S Benjamin, S Hall, E J Freireich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361223

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  7 in total

1.  A phase II trial of gallium nitrate in advanced previously untreated colorectal cancer.

Authors:  V A Canfield; A P Lyss
Journal:  Invest New Drugs       Date:  1993-11       Impact factor: 3.850

2.  Drug-induced ototoxicity.

Authors:  R E Brummett
Journal:  Drugs       Date:  1980-06       Impact factor: 9.546

Review 3.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

4.  Relative efficacy of chelating agents as antidotes for acute gallium nitrate intoxication.

Authors:  J L Domingo; J M Llobet; J Corbella
Journal:  Arch Toxicol       Date:  1987-02       Impact factor: 5.153

5.  Phase II evaluation of gallium nitrate by continuous infusion in breast cancer.

Authors:  K Jabboury; D Frye; F A Holmes; G Fraschini; G Hortobagyi
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

6.  Gain-of-Function Mutations in Acid Stress Response (evgS) Protect Escherichia coli from Killing by Gallium Nitrate, an Antimicrobial Candidate.

Authors:  Jie Zeng; Liwen Wu; Zhou Liu; Yihua Lv; Jinzhi Feng; Weijie Wang; Yunxin Xue; Dai Wang; Jiabin Li; Karl Drlica; Xilin Zhao
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

7.  Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro.

Authors:  Jingwu Li; Guang-Bin Wang; Xue Feng; Jing Zhang; Qin Fu
Journal:  Mol Med Rep       Date:  2015-11-19       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.